Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENESCO INCGCO · Entity 5742 | Director | July 24, 2026 | July 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENESCO INC
Report date July 24, 2026 · Filed July 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,006 |
Reported balance
After 2026-07-24 transaction · row 1
1 source rowRow 1 · 2026-07-24 · Grant · Acquired 3,905 · Balance 19,006 F1: Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2026 Filed Jul 24, 2026 20:02 UTC | GENESCO INC GCO · Entity 5742 | GrantCommon Stock | 3,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-316050 · ownership.xml · nonDerivative · entry 1 Bojanowski Carolyn · CIK 0001964380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,006 F1 · shares: Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:03 UTC | GENESCO INC GCO · Entity 5742 | GrantCommon Stock | 5,393 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-091539 · ownership.xml · nonDerivative · entry 1 Bojanowski Carolyn · CIK 0001964380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,101 F1 · shares: Grant of restricted stock under the Third Amended and Restated 2020 Equity Incentive Plan. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 20:05 UTC | GENESCO INC GCO · Entity 5742 | GrantCommon Stock | 4,540 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-079577 · ownership.xml · nonDerivative · entry 1 Bojanowski Carolyn · CIK 0001964380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,708 F1 · shares: Grant of restricted stock under the Second Amended and Restated 2020 Equity Incentive Plan. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 20:05 UTC | GENESCO INC GCO · Entity 5742 | GrantCommon Stock | 4,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039675 · doc4.xml · nonDerivative · entry 1 Bojanowski Carolyn · CIK 0001964380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,168 F1 · shares: Grant of restricted stock under the 2020 Equity Incentive Plan. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:00 UTC | GENESCO INC GCO · Entity 5742 | PurchaseCommon Stock | 510 | $49.01 | $24,995.10 |
DisclosureSEC source: 0001209191-23-006751 · doc4.xml · nonDerivative · entry 1 Bojanowski Carolyn · CIK 0001964380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.